Search Results for "Speciality European Pharma Limited"
Original Source: Speciality European Pharma
Matching Channels
Lyxumia® is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) for the treatment of patients with type 2 diabetes mellitus. GLP-1 is a naturally-occurring peptide hormone that is re...
The European Organization for Rare Diseases considers orphan diseases to be those that are rare (occur in 1 in 1500 to 1 in 2500 patients, according to US Rare Disease Act 2002 and European Commissi...
The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...
The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...
Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...
Matching News
Cinven acquires Mercury Pharma for $732 million
Investor HgCapital has sold British pharmaceutical company Mercury Pharma to private equity firm Cinven for 465 million pounds ($732 million). Cinven, the European private equity firm, reached agreeme...
Jobs under threat in Actelion cost saving
Swiss speciality pharmaceutical company Actelion has unveiled a new cost saving plan which could include the loss of 260 jobs across the organisation. The company says the plan will address cost...
Amdipharm and Mercury Pharma merge
As has been expected, Amdipharm and Mercury Pharma - both subsidiaries of Channel Islands-based private equity firm Cinven - have merged to create a single, consolidated, international speciality phar...
CPhI NEWS: AndersonBrecon undertakes second major expansion in 2012
Purpose-built facility dedicated to potent compounds doubles speciality pharma capabilities
BioAlliance Pharma licenses oncology product to Vestiq Pharmaceuticals
BioAlliance Pharma SA has completed a licensing agreement with Vestiq Pharmaceuticals for Vestiq to commercialise its product Oravig in the USA for the treatment of oropharyngeal candidiasis in adults...
European Digital Pharma Experts To Meet In Prague, 16-17 May 2013
This May, the Digital Pharma Experience in Prague, is the meeting point for some of Europe's most prominent digital pharma experts. At this innovative event, senior representatives from Pfizer, Novart...
Solvay doubles speciality fluorinated derivatives capacity
Solvay is doubling its production capacity for speciality fluorinated aliphatic derivatives at its Salindres, France plant to meet growing demand in strategic markets, including pharmaceuticals. The G...
New Maryland Law Enables Consumers To Select Qualified Physicians
A new Maryland law effective today requires physicians who publicize board certification to announce their certifying board as well as their speciality. Additionally, the law states the only acceptabl...
Matching PubMed Articles
A short history of spinal training and outlook on spine speciality development in the UK 1948-2013.
The development of a new speciality training programme in obstetrics and gynaecology in the UK.
In 2004, the Royal College of Obstetricians and Gynaecologists (RCOG) established a working group of experienced Fellows, Members, trainees and educationalists, who were responsible for writing and co...
A trans-disciplinary overview of case reports of thunderstorm-related asthma outbreaks and relapse.
European Society of Endodontology. Accreditation of postgraduate speciality training programmes in Endodontology. Minimum criteria for training Specialists in Endodontology within Europe. Internationa...
